Institutional investors purchased a net $367.0 thousand shares of THRX during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 85.39% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 1.3 Million shares of Theravance Inc
CLEARLINE CAPITAL LP Bought 1.1 Million shares of Theravance Inc
INVESCO POWERSHARES CAPITAL MANA... Bought 990.7 Thousand shares of Theravance Inc